Exagen Inc. XGN Reportable Segment — Interest Expense, Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s reportable segment — interest expense, nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s reportable segment — interest expense, nonoperating?
- Exagen Inc. (XGN) reported reportable segment — interest expense, nonoperating of $1.27M in Q1 2026.
- How has Exagen Inc.'s reportable segment — interest expense, nonoperating changed year-over-year?
- Exagen Inc.'s reportable segment — interest expense, nonoperating increased by 132.5% year-over-year, from $545K to $1.27M.
- What is the long-term trend for Exagen Inc.'s reportable segment — interest expense, nonoperating?
- Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — interest expense, nonoperating has grown at a 36.0% compound annual growth rate (CAGR), from $2.34M to $4.32M.
- What does reportable segment — interest expense, nonoperating mean?
- Costs associated with the segment's financing activities that are not directly related to core operations, such as interest paid on debt obligations. This metric reflects the financial leverage and capital structure costs allocated to the segment. High levels of interest expense can significantly impact the segment's overall bottom-line performance.